AAAAAA
Results:
1-13
|
Results: 13
Authors:
Michieli, M
Michelutti, A
Damiani, D
Ermacora, A
Masolini, P
Stocchi, R
Russo, D
Citation: M. Michieli et al., Amifostine does not inhibit the toxic effects of Anthracycline derivates or Mitoxantrone on MDR tumor cell lines, LEUK LYMPH, 42(4), 2001, pp. 721-729
Authors:
Ermacora, A
Michieli, M
Pea, F
Visani, G
Bucalossi, A
Russo, D
Citation: A. Ermacora et al., Liposome encapsulated daunorubicin (daunoxome) for acute leukemia, HAEMATOLOG, 85(3), 2000, pp. 324-325
Authors:
Silvestri, F
Sperotto, A
Ermacora, A
Fanin, R
Damiani, D
Baccarani, M
Citation: F. Silvestri et al., Lamivudine for the prevention of hepatitis B virus reactivation during autologous stem cell transplantation. A case report, HAEMATOLOG, 85(3), 2000, pp. 327-329
Authors:
Pea, F
Russo, D
Michieli, M
Baraldo, M
Ermacora, A
Damiani, D
Baccarani, M
Furlanut, M
Citation: F. Pea et al., Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia, CANC CHEMOT, 46(4), 2000, pp. 279-286
Authors:
Michieli, M
Damiani, D
Ermacora, A
Geromin, A
Michelutti, A
Masolini, P
Baccarani, M
Citation: M. Michieli et al., P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia, BR J HAEM, 108(4), 2000, pp. 703-709
Authors:
Silvestri, F
Ermacora, A
Sperotto, A
Patriarca, F
Zaja, F
Damiani, D
Fanin, R
Baccarani, M
Citation: F. Silvestri et al., Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation, BR J HAEM, 108(2), 2000, pp. 394-396
Authors:
Donini, A
Baccarani, U
Terrosu, G
Corno, V
Ermacora, A
Pasqualucci, A
Bresadola, F
Citation: A. Donini et al., Laparoscopic vs open splenectomy in the management of hematologic diseases, SURG ENDOSC, 13(12), 1999, pp. 1220-1225
Authors:
Michieli, M
Damiani, D
Ermacora, A
Masolini, P
Michelutti, A
Baccarani, M
Citation: M. Michieli et al., Liposome encapsulated daunorubicin doubles anthracycline toxicity in cell lines showing a non-PGP related multidrug resistance, HAEMATOLOG, 84(12), 1999, pp. 1151-1152
Authors:
Zaja, F
Russo, D
Fuga, G
Patriarca, F
Ermacora, A
Baccarani, M
Citation: F. Zaja et al., Rituximab for the treatment of type II mixed cryoglobulinemia, HAEMATOLOG, 84(12), 1999, pp. 1157-1158
Authors:
Patriarca, F
Ermacora, A
Skert, C
Citation: F. Patriarca et al., Pleural involvement in a case of monocytoid B-cell lymphoma, HAEMATOLOG, 84(10), 1999, pp. 949-950
Authors:
Pea, F
Damiani, D
Michieli, M
Ermacora, A
Baraldo, M
Russo, D
Fanin, R
Baccarani, M
Furlanut, M
Citation: F. Pea et al., Multidrug resistance modulation in vivo: The effect of cyclosporin A aloneor with dexverapamil on idarubicin pharmacokinetics in acute leukemia, EUR J CL PH, 55(5), 1999, pp. 361-368
Authors:
Michieli, M
Damiani, D
Ermacora, A
Masolini, P
Michelutti, A
Michelutti, T
Russo, D
Pea, F
Baccarani, M
Citation: M. Michieli et al., Liposome-encapsulated daunorubicin for PGP-related multidrug resistance, BR J HAEM, 106(1), 1999, pp. 92-99
Authors:
Michieli, M
Damiani, D
Ermacora, A
Masolini, P
Raspadori, D
Visani, G
Scheper, RJ
Baccarani, M
Citation: M. Michieli et al., P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications, BR J HAEM, 104(2), 1999, pp. 328-335
Risultati:
1-13
|